Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Leases (2022 - 2025)

LifeStance Health (LFST) has disclosed Current Leases for 4 consecutive years, with $45.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases fell 7.9% to $45.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.5 million, a 7.9% decrease, with the full-year FY2025 number at $45.5 million, down 7.9% from a year prior.
  • Current Leases was $45.5 million for Q4 2025 at LifeStance Health, down from $47.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $49.7 million in Q1 2024 to a low of $38.8 million in Q4 2022.
  • A 4-year average of $46.0 million and a median of $47.1 million in 2025 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: grew 19.71% in 2023, then dropped 7.9% in 2025.
  • LifeStance Health's Current Leases stood at $38.8 million in 2022, then increased by 19.71% to $46.5 million in 2023, then grew by 6.4% to $49.4 million in 2024, then decreased by 7.9% to $45.5 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Current Leases are $45.5 million (Q4 2025), $47.4 million (Q3 2025), and $47.1 million (Q2 2025).